UPDATE: Morgan Stanley Downgrades Solazyme On Lack Of Conviction In Long-Term Outcome
November 10, 2014 at 09:35 AM EST
In a report published Monday, Morgan Stanley analyst Timothy Radcliff downgraded the rating on Solazyme Inc (NASDAQ: SZYM) from ...